Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | OPC | - | - | - | - | [1] 6 6 💬
|
| 2 | OPC-41061 | - | - | - | - | [1] 67 67 💬
|
| 3 | OPC-41061 (tolvaptan) | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 4 | OPC-6535 | - | - | - | - | [2] 96 96, 97 💬
|
| 5 | OPC-6535 Tablets (drug) | - | - | - | - | [1] 97 97 💬
|
| 6 | OPC-6535(Tetomilast) | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 💬
|
| 7 | Opicapone (OPC) | [1] Opicapone Opicapone | [1] Opicapone
Opicapone
💬
| [1] COMT COMT 💬
| [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 8 | TOLVAPTAN (OPC-41061) | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|